PMVP Pharmaceuticals updates interim ovarian cancer monotherapy data
PMV Pharmaceuticals announced updated interim ovarian cancer data from its PYNNACLE Phase 2 pivotal trial for rezatapopt monotherapy.
Story updates
08:07:53 PM UTC
SquawkNews
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.